The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
Mohammad Luqman(Novartis (United States)), Anas Younes(Memorial Sloan Kettering Cancer Center)
Cited by 103
Related Papers
Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors
|Clinical Cancer Research|2004|109
The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
|Blood Cancer Journal|2011|70
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
|Oncotarget|2017|67